Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ZAVESCA
- Safety and Efficacy of Miglustat in Chinese NPC Patients
- Effects of Miglustat Therapy on Infantile Type of Sandhoff and Taysachs Diseases (EMTISTD)
- Miglustat on Gaucher Disease Type IIIB
- A Pilot Study of Zavesca® in Patients With Pompe Disease and Infusion Associated Reaction
- Two Period / Two Treatment Cross-over to Assess the Effect of Florastor® on Gastrointestinal Tolerability, Safety, and PK in Healthy Subjects Receiving Zavesca®
- Application of Miglustat in Patients With Niemann-Pick Type C
- Observational Study for Subjects With Pompe Disease Undergoing Immune Modulation Therapies
- Pharmacokinetics, Safety and Tolerability of Zavesca (Miglustat) in Patients With Infantile Onset Gangliosidosis: Single and Steady State Oral Doses
- Miglustat / OGT 918 in the Treatment of Cystic Fibrosis
- Miglustat in Niemann-Pick Type C Disease
- Pharmacokinetics and Tolerability of Zavesca® (Miglustat) In Patients With Juvenile GM2 Gangliosidosis
- Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease
Clinical trials list
click for details